{"date":"2025-07-24","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1271-2025-07-24-1918-qmmwae","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-07-24","time":"19:18:10","subject":"公告本公司董事會決議召開114年第一次股東臨時會相關事宜","clause":"第32款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-07-24 19:18，「公告本公司董事會決議召開114年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-07-24-1912-c9oids","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-07-24","time":"19:12:19","subject":"本公司擬辦理私募普通股或私募國內可轉換公司債","clause":"第9款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-07-24 19:12，「本公司擬辦理私募普通股或私募國內可轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-07-24-1911-1361kdk","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-07-24","time":"19:11:40","subject":"公告本公司董事會決議授權董事長投資額度案","clause":"第44款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-07-24 19:11，「公告本公司董事會決議授權董事長投資額度案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-07-24-1909-1qtka21","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-07-24","time":"19:09:17","subject":"公告本公司董事會選任副董事長","clause":"第6款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-07-24 19:09，「公告本公司董事會選任副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-07-24-1757-87qz4w","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-07-24","time":"17:57:07","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-07-24 17:57，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-07-24-1640-s364tb","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-07-24","time":"16:40:04","subject":"公告本公司訂定除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-07-24 16:40，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-07-24-1633-o2707j","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-07-24","time":"16:33:09","subject":"公告本公司與PT MAJU MAKMUR UTOMO簽訂經銷合約","clause":"第10款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-07-24 16:33，「公告本公司與PT MAJU MAKMUR UTOMO簽訂經銷合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-07-24-1619-way5t9","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-07-24","time":"16:19:30","subject":"公告本公司國內第三次無擔保轉換公司債完成訂價","clause":"第51款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-07-24 16:19，「公告本公司國內第三次無擔保轉換公司債完成訂價」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-07-24-1537-w5lb1p","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-07-24","time":"15:37:56","subject":"本公司受邀參加櫃買中心與元大證券合辦之「臺灣生技產業高峰論壇」","clause":"第12款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-07-24 15:37，「本公司受邀參加櫃買中心與元大證券合辦之「臺灣生技產業高峰論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-07-24-1518-6w655t","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-07-24","time":"15:18:51","subject":"公告本公司董事會決議辦理初次上市掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-07-24 15:18，「公告本公司董事會決議辦理初次上市掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-07-24-1518-nhbes6","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-07-24","time":"15:18:13","subject":"公告本公司董事會通過114年第二季個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-07-24 15:18，「公告本公司董事會通過114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-07-24-1408-1aq7iqo","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-07-24","time":"14:08:29","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-07-24 14:08，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2025-07-24-1346-1ir217o","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2025-07-24","time":"13:46:56","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年8月4日","clause":"第31款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2025-07-24 13:46，「公告本公司114年第二季財務報告董事會預計召開日期為114年8月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-07-24-1330-1kqsn3a","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-07-24","time":"13:30:04","subject":"公告本公司114年第2季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-07-24 13:30，「公告本公司114年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}